1. A researcher suspects that the actual prevalence of generalized anxiety among children and adolescents is higher than the previously reported prevalence of generalized anxiety disorder among children and adolescents. The previously reported prevalence of generalized anxiety disorder among children and adolescents is 3.9%, and the researcher conducts a study to test the accuracy of the previously reported prevalence of generalized anxiety disorder by recruiting 98 children and adolescents from various pediatricians' offices and tests them for generalized anxiety disorder using the DSM-5. The researcher determines that the prevalence of generalized anxiety disorder among the participants of the study is 6.1%. The researcher's hypothesis, for a level of significance of 5%, should resemble which of the following sets of hypotheses?

A) H₀:p > .039; H₁:p = .039; alpha= .05

B) H₀:p = .039; H₂:p > .039; alpha= .05

C) H₀:p > .039; H1:p = .039; alpha= .95

D) H₀:p = .039; H2:p > .039; alpha= .95

2. A researcher suspects that the actual prevalence of generalized anxiety among children and adolescents is higher than the previously reported prevalence of generalized anxiety disorder among children and adolescents. The previously reported prevalence of generalized anxiety disorder among children and adolescents is 3.9%, and the researcher conducts a study to test the accuracy of the previously reported prevalence of generalized anxiety disorder by recruiting 98 children and adolescents from various pediatricians' offices and tests them for generalized anxiety disorder using the DSM-5. The researcher determines that the prevalence of generalized anxiety disorder among the participants of the study is 6.1%. Calculate thez value for the test statistic.

A)z = 1.12

B)z = 1.09

C)z = 0.92

D)z = -57.53

3. A researcher suspects that the actual prevalence of generalized anxiety among children and adolescents is higher than the previously reported prevalence of generalized anxiety disorder among children and adolescents. The previously reported prevalence of generalized anxiety disorder among children and adolescents is 3.9%, and the researcher conducts a study to test the accuracy of the previously reported prevalence of generalized anxiety disorder by recruiting 98 children and adolescents from various pediatricians' offices and tests them for generalized anxiety disorder using the DSM-5. The researcher determines that the prevalence of generalized anxiety disorder among the participants of the study is 6.1%. For a level of significance of 5%, what should the researcher's decision rule look like?

A) Reject H₀ifz is less than or equal to -1.645.

B) Reject H₀ ifz is greater than or equal to 1.645.

C) Reject H₀ ifz is less than or equal to -1.96.

D) Reject H₀ ifz is greater than or equal to 1.96.

4. A researcher suspects that the actual prevalence of generalized anxiety among children and adolescents is higher than the previously reported prevalence of generalized anxiety disorder among children and adolescents. The previously reported prevalence of generalized anxiety disorder among children and adolescents is 3.9%, and the researcher conducts a study to test the accuracy of the previously reported prevalence of generalized anxiety disorder by recruiting 98 children and adolescents from various pediatricians' offices and tests them for generalized anxiety disorder using the DSM-5. The researcher determines that the prevalence of generalized anxiety disorder among the participants of the study is 6.1%. What should the researcher's conclusion be for a 5% significance level?

A) We reject H₀ at the 5% level because -57.53 is less than -1.96. We do have statistically significant evidence to show the actual prevalence of generalized anxiety disorder among children and adolescents is above the previously reported prevalence of 3.9%.

B) We fail to reject H₀ at the 5% because .092 is less than 1.645. We do not have statistically significant evidence to show the actual prevalence of generalized anxiety disorder among children and adolescents is above the previously reported prevalence of 3.9%.

C) We fail to reject H₀ at the 5% because 1.09 is less than 1.96. We do not have statistically significant evidence to show the actual prevalence of generalized anxiety disorder among children and adolescents is above the previously reported prevalence of 3.9%.

D) We fail to reject H₀ at the 5% because -1.12 is greater than -1.645. We do not have statistically significant evidence to show the actual prevalence of generalized anxiety disorder among children and adolescents is above the previously reported prevalence of 3.9%.

5. A new drug to treat psoriasis has been developed and is in clinical testing. Assume that those individuals given the drug are examined before receiving the treatment and then again after receiving the treatment to determine if there was a change in their symptom status. If the initial results showed that 2.0% of individuals entered the study in remission, 77.0% of individuals entered the study with mild symptoms, 16.0% of individuals entered the study with moderate symptoms, and 5.0% entered the study with severe symptoms calculate and interpret a chi-squared test to determine if the drug was effective treating psoriasis given the information below from the final examination.

	Remission (No Symptoms of Psoriasis)	Mild Symptoms of Psoriasis	Moderate Symptoms of Psoriasis	Severe Symptoms of Psoriasis	Total Number of Participants to Receive the Drug
Number of Participants	380	520	95	5	1000

A) We reject H₀ because 6628.08 is greater than 5.99. We have statistically significant evidence at the alpha equals .05 level to show that the distribution of the severity of psoriasis cases at the end of the clinical trial for the sample is different from the distribution of the severity of psoriasis cases prior to the administration of the drug, suggesting the drug is effective.

B) We reject H₀ because 6628.08 is greater than 7.81. We have statistically significant evidence at the alpha equals .05 level to show that the distribution of the severity of psoriasis cases at the end of the clinical trial for the sample is different from the distribution of the severity of psoriasis cases prior to the administration of the drug, suggesting the drug is effective.

C) We reject H₀ because 6628.08 is greater than 9.49. We have statistically significant evidence at the alpha equals .05 level to show that the distribution of the severity of psoriasis cases at the end of the clinical trial for the sample is different from the distribution of the severity of psoriasis cases prior to the administration of the drug, suggesting the drug is effective.

D) We reject H₀ because 6628.08 is greater than 11.07. We have statistically significant evidence at the alpha equals .05 level to show that the distribution of the severity of psoriasis cases at the end of the clinical trial for the sample is different from the distribution of the severity of psoriasis cases prior to the administration of the drug, suggesting the drug is effective.

1. True or False? For a two-tailed test usingz values at the .05% significance level we reject H₀ ifz < -1.960 or ifz > 1.960.

2. Assume a researcher recruits 150 African American and Caucasian individuals taking warfarin to determine if there is a difference in the mean dosage of the medication needed to cause a decrease in their INR blood test. The mean dosage for 75 Caucasian individuals required to get their INR blood test in range is 6.1 mg with a standard deviation of 1.7 mg and the mean dosage for 75 African American individuals required to get their INR blood test in range is 4.3 mg with a standard deviation of 0.9 mg. Please calculate the S_p value.

3. Assume a researcher recruits 150 African American and Caucasian individuals taking warfarin to determine if there is a difference in the mean dosage of the medication needed to cause a decrease in their INR blood test. If the mean dosage for 75 Caucasian individuals required to get their INR blood test in range is 6.1 mg with a standard deviation of 1.7 mg and the mean dosage for 75 African American individuals required to get their INR blood test in range is 4.3 mg with a standard deviation of 0.9 mg, Please calculate thez value.

4. True or False? Assume a researcher recruits 150 African American and Caucasian individuals taking warfarin to determine if there is a difference in the mean dosage of the medication needed to cause a decrease in their INR blood test. If the mean dosage for 75 Caucasian individuals required to get their INR blood test in range is 6.1 mg with a standard deviation of 1.7 mg and the mean dosage for 75 African American individuals required to get their INR blood test in range is 4.3 mg with a standard deviation of 0.9 mg, the decision rule for a 10% level of significance would be to reject H₀ ifz < -1.645 orz > 1.645.